Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Janus family kinases inhibitors (JAKis) are a new class of compounds that may well serve this purpose. JAK-inhibitors are a promising class of oral compounds in moderate-severe Crohn’s Disease (CD). Further clinical trials are necessary in order to implement the available knowledge, especially on their long-term safety issues.
…